Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers M > Headlines for Merck & Co., Inc. > News item |
Merck intends to price notes in five-, 10-, 30-year maturities
By Andrea Heisinger
New York, Sept. 10 - Merck & Co., Inc. is expected to price a note offering in three tranches on Monday, according to a filing with the Securities and Exchange Commission.
The notes (A1/AA) will be priced in tranches due 2018, 2022 and 2042.
Bookrunners are Bank of America Merrill Lynch, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC.
Proceeds will be used for general corporate purposes, including making contributions to pension plans and repaying outstanding commercial paper borrowings and upcoming debt maturities.
The global health care company is based in Whitehouse Station, N.J.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.